FTV Management Company’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-32,440,463
Closed -$360M 2
2025
Q1
$360M Hold
32,440,463
100% 1
2024
Q4
$334M Hold
32,440,463
100% 1
2024
Q3
$308M Hold
32,440,463
100% 1
2024
Q2
$276M Hold
32,440,463
100% 1
2024
Q1
$300M Hold
32,440,463
100% 1
2023
Q4
$315M Hold
32,440,463
100% 1
2023
Q3
$291M Hold
32,440,463
100% 1
2023
Q2
$364M Buy
32,440,463
+1,142,857
+4% +$10.1M 98.03% 1
2023
Q1
$329M Hold
31,297,606
97.67% 1
2022
Q4
$303M Hold
31,297,606
90.28% 1
2022
Q3
$386M Hold
31,297,606
92.5% 1
2022
Q2
$320M Hold
31,297,606
81.08% 1
2022
Q1
$398M Hold
31,297,606
75.76% 1
2021
Q4
$655M Buy
+31,297,606
New +$632M 84.44% 1

Other funds holding ENFN

FTV Management Company's ENFN Position: Q2 2025 in Review

FTV Management Company sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 32,440,463 shares — an estimated $360M sold.

FTV Management Company first reported a position in ENFN in Q4 2021 and held it in 14 quarters. The position peaked at $655M in Q4 2021. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

  • FTV Management Company reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
  • FTV Management Company sold 32,440,463 Enfusion, Inc. shares in Q2 2025, an estimated $360M.
  • FTV Management Company first reported a position in Enfusion, Inc. in Q4 2021 and held it in 14 quarters.
  • FTV Management Company's Enfusion, Inc. position peaked at $655M in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on FTV Management Company's 13F filing for Q2 2025, filed 13 Aug 2025.